These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2301343)

  • 21. Interferon treatment in acute progressive and fulminant hepatitis.
    Levin S; Leibowitz E; Torten J; Hahn T
    Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
    Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of alpha-interferon and gamma-interferon in patients with acute and chronic viral hepatitis.
    Kakumu S; Fuji A; Yoshioka K; Tahara H
    Hepatogastroenterology; 1989 Apr; 36(2):97-102. PubMed ID: 2499528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.].
    Cornberg M; Manns MP
    Pharm Unserer Zeit; 2011 Jan; 40(1):45-51. PubMed ID: 21194082
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute infection by hepatitis B virus].
    Alegre F; Moreno D; Quiroga J
    An Sist Sanit Navar; 2004; 27 Suppl 2():17-25. PubMed ID: 15381939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment of chronic viral hepatitis with recombinant alpha-2 interferon: meta analysis and clinical contribution].
    Raffa S; Albiani B; Allegritti A; Fontana M; Loria C; Manzi P; Sottili S; Grassi M
    Clin Ter; 1997 Oct; 148(10):421-35. PubMed ID: 9470304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
    Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
    Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G; Fazio V; Tantimonaco G
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hepatitis B.
    Hoofnagle JH
    N Engl J Med; 1990 Aug; 323(5):337-9. PubMed ID: 2366843
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon for chronic viral hepatitis.
    Med Lett Drugs Ther; 1990 Jan; 32(809):1-2. PubMed ID: 2104647
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the interferon status of patients with viral hepatitis B when genetically engineered alpha 2-interferon is used].
    Pokrovskiĭ VI; Malinovskaia VV; Murzabaeva RT; Vasil'eva VI; Asratian AA
    Vopr Virusol; 1990; 35(2):135-8. PubMed ID: 2117831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant alpha2-interferon substances in treating patients with acute hepatitis B with a mild course].
    Malinovskaia VV; Neumoina MV; Bragina GS
    Vopr Virusol; 1997; 42(4):182-5. PubMed ID: 9304301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The reaferon treatment of a patient with acute viral hepatitis B and hemorrhagic vasculitis].
    Fedorchenko SV; Tereshchenko TM
    Vrach Delo; 1990 Oct; (10):104-5. PubMed ID: 2080557
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy and prognosis of the acute hepatitis B].
    Uemura K; Kiyosawa K
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):444-9. PubMed ID: 12442424
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis B: clinical manifestations, diagnosis and medical management].
    Pirovino M
    Soz Praventivmed; 1998; 43 Suppl 1():S14-7, S88-91. PubMed ID: 9833257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Articular symptoms as a clinical presentation of acute viral B hepatitis].
    Encinas Sotillos A; Romero Ganuza FJ; Hernández Navarrete C; Granados Menéndez MI
    Rev Clin Esp; 1991 Jul; 189(3):155. PubMed ID: 1947396
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunomodulators in acute prolonged hepatitis.
    Kabeer MA
    J Assoc Physicians India; 2001 Feb; 49():300. PubMed ID: 11225162
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiology, diagnosis and treatment for acute hepatitis B].
    Yatsuhashi H; Nagaoka S; Tamada Y
    Nihon Rinsho; 2011 May; 69 Suppl 4():440-5. PubMed ID: 22096958
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatitis B. Epidemiology, etiology, diagnosis, development, prognosis, principles of treatment].
    Pawlotsky JM; Dhumeaux D
    Rev Prat; 1992 Mar; 42(5):616-24. PubMed ID: 1604192
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical feature and course of acute hepatitis type B].
    Arakawa Y; Tanaka N; Moriyama M
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):427-32. PubMed ID: 12442421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.